Home › Neuroblastoma › Massachusetts › Boston

Pag-aaral pangklinika para sa Neuroblastoma sa Boston, MA

Isang pag-aaral para sa Neuroblastoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Boston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Nagre-recruitPhase 3

Massachusetts General Hospital Cancer Center, Boston
Dana-Farber Cancer Institute, Boston

Hanggang edad 30 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06172296

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Nagre-recruitPhase 1/2

Dana-Farber Cancer Institute ( Site 1013), Boston

6 Months – 25 Years · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06395103

B7-H3.CD28Z.CART in Solid Tumors

Nagre-recruitPhase 1

Dana Farber Cancer Institite, Boston

9 Months – 30 Years · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07358260

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Nagre-recruitPhase 3

Massachusetts General Hospital Cancer Center, Boston
Dana-Farber Cancer Institute, Boston

365 Days – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Nagre-recruitPhase 1/2

Dana-Farber Cancer Institute, Boston

12 Months – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04851119

SPEARHEAD-3 Pediatric Study

Nagre-recruitPhase 1/2

Dana Farber Cancer Institute, Boston

Edad 2 hanggang 21 · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05642455

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

Nagre-recruitPhase 1/2

Boston Children's Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT06721689

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

Nagre-recruitPhase 2

Boston Children's Hospital, Dana-Farber Cancer Institute., Boston

Edad 1 hanggang 31 · Lahat ng kasarian · Na-update Hul 20, 2026 · NCT06450041

Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma

Nagre-recruitPhase 1

Boston Children's Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT07027748

Neuroblastoma Biology Study

Nagre-recruitObservasyonal na pag-aaral

Children's Hospital Boston, Boston

31 Days – 99 Years · Lahat ng kasarian · Na-update Mar 23, 2026 · NCT01587300

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

Nagre-recruit

Dana-Farber Cancer Institute, Boston

Hanggang edad 17 · Lahat ng kasarian · Na-update Peb 10, 2026 · NCT06831552

Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma

Nagre-recruitPhase 1/2

Boston Children's Hospital, Boston
Dana-Farber Cancer Institute, Boston

12 Months – 29 Years · Lahat ng kasarian · Na-update Dis 26, 2025 · NCT06803875

MCT for the Harvard/UCSF ROBIN Center

Nagre-recruit

Brigham and Women's Hospital, Boston

Lahat ng edad · Lahat ng kasarian · Na-update Peb 17, 2025 · NCT06000787

Pag-aaral para sa Neuroblastoma sa ibang lungsod

Iba pang pag-aaral sa Boston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.